Ivermectin as a possible treatment for COVID-19

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2020

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information

INTERVENTION:

Intervention1: Ivermectin: 12 mg orally to be administered once daily on days 1 and 2 Control Intervention1: Placebo tablets: A placebo tablet similar to Ivermectin 12 mg (provided by the manufacturer) to be given once daily on days 1 and 2.

CONDITION:

Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere

PRIMARY OUTCOME:

Negative RT‐PCRTimepoint: Day 6

SECONDARY OUTCOME:

Discharge by day 10Timepoint: Day 10 ICU AdmissionTimepoint: NA In‐hospital mortalityTimepoint: NA Mechanical VentilationTimepoint:

NA INCLUSION CRITERIA:

Patients admitted with COVID‐19 with mild to moderate severity
Epistemonikos ID: a1f5728b13effaf47c0f65346d2432799d42a010
First added on: Sep 10, 2020